Bicycle Therapeutics (BCYC) Debt to Equity (2020 - 2024)
Bicycle Therapeutics' Debt to Equity history spans 5 years, with the latest figure at $0.04 for Q2 2024.
- For Q2 2024, Debt to Equity fell 74.48% year-over-year to $0.04; the TTM value through Jun 2024 reached $0.04, down 74.48%, while the annual FY2023 figure was $0.08, 26.08% down from the prior year.
- Debt to Equity reached $0.04 in Q2 2024 per BCYC's latest filing, down from $0.09 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.21 in Q2 2021 to a low of $0.04 in Q2 2024.
- Average Debt to Equity over 5 years is $0.12, with a median of $0.11 recorded in 2022.
- Peak YoY movement for Debt to Equity: soared 43.21% in 2023, then plummeted 74.48% in 2024.
- A 5-year view of Debt to Equity shows it stood at $0.15 in 2020, then tumbled by 43.22% to $0.09 in 2021, then increased by 29.76% to $0.11 in 2022, then decreased by 26.08% to $0.08 in 2023, then plummeted by 57.26% to $0.04 in 2024.
- Per Business Quant, the three most recent readings for BCYC's Debt to Equity are $0.04 (Q2 2024), $0.09 (Q1 2024), and $0.08 (Q4 2023).